Introduction
============

Diabetes is a major global health problem, which currently affects millions of people worldwide with high and escalating costs to societies.[@b1-clep-7-421],[@b2-clep-7-421] We have established the Diabetes Impact Study 2013 with the aim to provide an updated account of the current and future epidemiological profile of diabetes in Denmark together with an appraisal of the costs to patients and society that is attributable to diabetes. The study takes advantage of the establishment of the Danish National Diabetes Register (NDR) in 2006[@b3-clep-7-421] which, together with the high quality of Danish health registers, offers unique opportunities for epidemiological and public health research in diabetes.[@b4-clep-7-421]

Here, we present the Diabetes Impact Study 2013 and the first epidemiological results, with focus on the trends in the incidence, the mortality, and the resulting prevalence of diabetes in Denmark from 2000 to 2011. As a novelty, we also introduce the framework of using register data to classify diabetes by complications status to investigate the epidemiological characteristics of chronic complications of diabetes.

Patients and methods
====================

Data sources
------------

NDR is established on the basis of information contained in already existing Danish health registers,[@b3-clep-7-421] including the Danish National Patient Register (DNPaR),[@b5-clep-7-421] the Danish National Prescription Registry,[@b6-clep-7-421] and the Danish National Health Service Register.[@b7-clep-7-421] Linkage of person-specific data between the registers is possible using the personal identification number that is assigned to each Danish citizen and is used for administrative purposes throughout the public and private sectors in Denmark. As previously summarized,[@b3-clep-7-421],[@b8-clep-7-421] inclusion in NDR takes place for a given person when the first of several possible ascertainment criteria are met: the first date of either a contact registered in the DNPaR with a diagnosis relevant to diabetes mellitus, fulfillment of specific criteria of purchasing prescriptions with either insulin or peroral antidiabetic drugs, fulfillment of one of two specific patterns of measurement of blood sugar, or a registration of a chiropodist service specifically provided to a person with diabetes.

All data on moves, migrations, and deaths recorded for the population of NDR registrants were obtained from the Danish Civil Registration System, which, since 1968, has kept electronic records on all demographic data for all Danish inhabitants.[@b9-clep-7-421]

NDR is supposed to cover all persons fulfilling inclusion criteria and being alive at the end of 1996 plus all persons with inclusion date since the start of 1997.

For the present analysis, a data set was extracted with all patients cumulatively registered with NDR on July 3, 2013 (n=497,232). For these patients, all contacts (regardless of the date of contact) in DNPaR were extracted, including coded data in all diagnostic and therapeutic interventions performed, together with information on primary and secondary diagnoses underlying the contact, the hospital, and all relevant dates related to the contact. DNPaR contains information on all activities in the Danish hospitals back to 1977 for inpatient contacts and 1995 for outpatient contacts, including visits to emergency rooms.[@b5-clep-7-421]

Establishing milestones in the lifetime cause of diabetes
=========================================================

By means of the personal identification number, data for each of the registrants in NDR were linked with DNPaR to establish relevant clinical milestones for each patient. These milestones included the date of first occurrence of the diagnosis of diabetes, and the date of first occurrence of codes classifying for chronic complications related to diabetes (see "Establishing the diagnosis of diabetes" section). Information from Danish Civil Registration System was used to establish the date of death (regardless of the cause of death) and the date of emigration as relevant.

Establishing the diagnosis of diabetes
======================================

The date of the clinical diagnosis of diabetes is not available in NDR and has been operationally established as the first date of fulfillment of a criterion for inclusion in NDR.[@b8-clep-7-421] If the first registration of a diagnosis or an intervention code specific for diabetes occurred in DNPaR for a patient before the date of inclusion registered with NDR, this date has been used as a proxy for the date of diagnosis. Otherwise, the date of inclusion in NDR has been used. The right column of [Table 1](#t1-clep-7-421){ref-type="table"} shows how groups of codes of diagnoses and interventions have been used in this process. The complete list of all the codes of diagnoses and interventions which qualify for the diagnosis of diabetes and related complications may be accessed from <http://www.appliedeconomics.dk/index.php/publications/reports-for-download>.

Occurrence and classification of complications relevant for diabetes
====================================================================

We have attempted to assess when a patient has developed chronic diabetes complications based on coded information from the DNPaR. In the absence of published guidelines, we have relied on consultations with clinical experts combined with decisions made on the basis of the actual distribution of relevant codes. This classification scheme comprises three complication groups on a tentative basis: without evidence of complications from available data (complication group 0, CG0); with evidence of at least one complication of intermediate impact (complication group 1, CG1); and with evidence of at least one complication of major impact (complication group 2, CG2). We have assumed irreversibility so that once qualified for CG1, the patient cannot revert to CG0 and can only remain in CG1 until death or progression to CG2. For patients with transition directly from CG0 to CG2, it has been assumed, for computational reasons, that the patient first progresses to CG1, but instantaneously progresses further to CG2 without producing person-time in CG1.

The date of progression to a given complication group has been taken as the first occurrence of a code of diagnosis or procedure registered in DNPaR qualifying for a CG. [Table 1](#t1-clep-7-421){ref-type="table"} (middle column) provides a summary of this information and the complete list of all the codes of diagnoses and interventions, which qualify for a complication group and may be accessed from <http://www.appliedeconomics.dk/index.php/publications/reports-for-download>. Codes not qualifying for any complication are assigned to CG0 by default.

Some codes of diagnoses and procedures are specific for diabetes (eg, diabetic retinopathy), while others are unspecific (eg, myocardial infarction and amputations). For patients having developed such complication(s) before the operational date of the diagnosis of diabetes, the patients will be assigned to the concerned CG at the date of diagnosis of diabetes and the patient can only contribute with person-time at risk for progression to a more advanced CG.

Framework of epidemiological analysis
=====================================

The epidemiological analyses of transition rates and prevalence proportions have been performed within the framework of an illness-stage-death model outline in [Figure 1](#f1-clep-7-421){ref-type="fig"}. The number of persons present in each of the stages, represented in the flow chart in [Figure 1](#f1-clep-7-421){ref-type="fig"}, on the last date of a given calendar year represents the prevalence of patients with the complication status for that year. These numbers provide for the annual complication-specific prevalence proportions by division with the total population size. Annual transition rates (incidence rate of the disease; morbidity rates reflecting rates of progression from CG0 to CG1 and from CG1 to CG2, respectively; and mortality rates from each of the complication groups) have been estimated from the numbers of transitions divided with the appropriate numbers of person-years at risk during the calendar year concerned.

For each calendar year, we calculated individual person-time, in terms of 1) the exact number of days experienced in any combination of 5-year age-groups; and 2) complication status based on the transition dates between age-groups and complication groups. Age groups were further collapsed to the groups: 0--24, 25--49, 50--74, and 75+ years. The analyses of morbidity and mortality were done on the basis of age standardization within each sex using the age composition of the population of persons with diabetes 2006 ultimo.

For the estimation of the incidence rate of diabetes, population time at risk of developing diabetes for each calendar year was obtained from Statistics Denmark,[@b10-clep-7-421] with subtraction of the person-time experienced with diabetes during that year in order to estimate true person-time at risk in the denominator. The analysis of incidence rate of diabetes was done on the basis of age standardization within each sex, using the age composition of the Danish population 2006 ultimo in four groups: 0--24, 25--49, 50--74, and 75+ years.[@b10-clep-7-421]

*χ*^2^-based analyses were employed to test for heterogeneity over calendar time. An approximated Poisson distribution and the binomial distribution for rates and proportions were used to calculate 95% confidence intervals.

Because we consider the first operational years of the NDR (1997--1999) as a running-in phase, the present analysis focuses on the period from 2000 to 2011.

Ethical aspects
===============

The Diabetes Impact Study 2013 is an observational register-based investigation with no contact to registered persons. Permission to extract and analyze data was obtained from the Danish Data Protection Agency (Jnr 2013-21-1749) and the Danish National Board of Health (FSEID-00000440).

Results
=======

As of July 3, 2013, a total of 497,232 persons were registered in NDR. After exclusion of 688 persons with invalid or inconsistent data, 496,514 persons (99.9% of all registrants) were included in the present analysis.[@b8-clep-7-421] [Table 2](#t2-clep-7-421){ref-type="table"} contains a summary of all events observed and inferred from the registry data by complication group for the total population, with stratification for men and women.

Incidence
=========

The trend in standardized incidence rate is shown in [Figure 2](#f2-clep-7-421){ref-type="fig"}, demonstrating an increasing incidence, with fluctuations. There is strong evidence of heterogeneity between calendar years (*P*\<0.001). In absolute numbers, the incidence increased from approximately 18,000 new cases in year 2000 to almost 32,000 new cases in year 2011, corresponding to an average annual increase at approximately 5%. The men:women standardized rate ratio over the period was 1.25 (*P*\<0.001). Approximately 75% of the persons with diabetes, slightly higher for women than for men, were without complications at diagnosis, and this proportion remained largely constant through the period of analysis ([Table 2](#t2-clep-7-421){ref-type="table"}).

Complications
=============

An increasing number of persons progressed to CG1 and CG2, respectively ([Table 2](#t2-clep-7-421){ref-type="table"}), over the period. However, when taking into consideration the person-time at risk of developing these complications, the rate of developing complications decreased for both complication groups ([Figure 3](#f3-clep-7-421){ref-type="fig"}), mostly pronounced for the category of severe complications (CG2). These trends were statistically significant for men as well as for women (*P*\<0.001). The rate of progression to CG1 was higher for men than for women, with a men:women standardized rate ratio at 1.37 (*P*\<0.001), whereas the rate of progression to CG2 was more similar, yet statistically significantly different, for men and women with men:women standardized rate ratio at 1.03 (*P*\<0.001).

Mortality
=========

The number of deaths (regardless of cause of death) increased slightly from approximately 8,300 in year 2000 to almost 12,000 in year 2011 ([Table 1](#t1-clep-7-421){ref-type="table"}). However, when taking into consideration the person-time at risk of dying in the various complication groups, the mortality rate decreased for both men and women and for all complication groups ([Figure 4](#f4-clep-7-421){ref-type="fig"}). Overall, the standardized mortality rate declined from 5.7 deaths per 100 person-years to 3.9 deaths per 100 person-years, corresponding with a decrease of 3% annually. The men:women standardized rate ratio was 1.29 (*P*\<0.001). The mortality rate was lowest for CG0, with a decline in the rate from 2.9 to 2.0 deaths per 100 person-years (men:women standardized rate ratio: 1.27, *P*\<0.001). The mortality rate was intermediate for CG1, with a decline in the mortality rate from 5.1 to 3.3 deaths per 100 person-years (men:women standardized rate ratio: 1.09, *P*\<0.001). The mortality rate was highest for CG2, with a decline in the mortality rate from 11.4 to 7.4 deaths per 100 person-years (men:women standardized rate ratio: 1.15, *P*\<0.001).

Prevalence
==========

The number of prevalent patients increased from approximately 140,000 patients at the end of the year 1999 to more than 300,000 at the end of the year 2011 ([Table 2](#t2-clep-7-421){ref-type="table"}). The standardized prevalence proportion increased from 28 per 1,000 population 1999 ultimo to 52 per 1,000 population 2011 ultimo ([Figure 5](#f5-clep-7-421){ref-type="fig"}). For each of the years covered by the study, men had a statistically significant (*P*\<0.001) higher prevalence proportion than women, with the men:women standardized proportion ratio ranging from 1.1 to 1.4. The relative prevalence of patients in CG0 fell slightly from approximately 58% at the end of 1999 to approximately 55% at the end of 2011 ([Figure 6](#f6-clep-7-421){ref-type="fig"}). This was caused by an increase in the proportion of patients in CG2 from less than 23% at the end of 1999 to more than 25% at the end of 2011, whereas the proportion of patients in CG1 was almost constant throughout the period of analysis. As compared with women, there were relatively fewer men in CG0 and relatively more men in both CG1 and CG2 (data not shown).

Discussion
==========

We have used already existing national health register data to establish a comprehensive characterization of the central epidemiological features of diabetes in Denmark, with all advantages and limitations attached to this approach.

Data from the nationwide Danish health registers are generally considered to have a very high level of completeness in terms of coverage of all the relevant persons and activities.[@b4-clep-7-421] Furthermore, using already existing data collected for purposes independent of the study concerned reduces both bias and need to collect additional data. Nevertheless, a series of limitations are involved when using NDR and the other Danish health registers for research purposes.[@b8-clep-7-421] Thus, NDR may include up to 20% registrants who do not have diabetes. A sensitivity analysis with exclusion of these persons yields a reduction of approximately 30% for all key figures presented in [Table 1](#t1-clep-7-421){ref-type="table"}, but with similar trends in the proportions and rates as found for the total material.

Another concern is that for more than 10% of the registrants, the operationally established date of diagnosis of diabetes is systematically biased toward too late a date.[@b8-clep-7-421] We have addressed this issue by using the full information available in DNPaR to establish the earliest possible date of registration with a diabetes-specific event.

Relevant data on diabetes and comorbidity captured in the primary health care sector are not available in NDR and DNPaR, including values of glycosylated hemoglobin as well as measurements of microalbuminuria and results of screening for diabetes eye complications. Such information would improve the classification of diabetic complications by severity.

The data extracted from the DNPaR may suffer from misclassifications and errors in coding practice, and in addition, cause omissions of otherwise relevant registrations; such errors may lead to misclassification of the date of onset of complications. Compared with previous epidemiological analyses based on NDR,[@b11-clep-7-421] our approach is novel as we attempted to assess complication status and categorize it by level of impact. Even though this may be questioned on clinical grounds, it seems to work at the group level as evidenced by the fact that the mortality level is higher for the group of patients with complications of moderate impact as compared with patients without complications, but is even higher in the group of patients with complications of severe impact.

With these limitations in mind, we believe our results accurately reflect the current trends in diabetes epidemiology in Denmark and extend previous epidemiological analyses based on NDR by confirming an increasing incidence level.[@b11-clep-7-421] Because the diagnosis of diabetes is established by means of the first occurrence of certain events, fluctuations in incidence occur as a consequence of changes in administrative practice, like reimbursement for services specific for patients with diabetes, but since the majority of patients are ascertained by hospital diagnoses or prescriptions with antidiabetic drugs, such explanation seems less likely.[@b8-clep-7-421] Alternatively, the increasing incidence level might be explained by increased awareness, leading to earlier diagnosis than in previous times. If so, it would be expected that the proportion of patients having signs of complications already at the time of diagnosis should decrease over time, but this is not the case, as evidenced in [Table 2](#t2-clep-7-421){ref-type="table"}. Currently, no data are available to assess the impact of changes in overweight and obesity on the incidence rate of diabetes, thus making further investigations highly needed.

We find that the prevalence of diabetes is increasing exponentially as evidenced by the net influx to the population of patients with diabetes (ie, the difference between the annual number of new cases and the annual number of deaths), which is steadily increasing. Our study demonstrates that this trend is driven not only by an increasing incidence, but also by a decreasing trend in the risk of developing complications as well as a decreasing mortality level regardless of the presence of complications, but with most reduction among patients with severe complications. These trends have been observed also in subsets of patients attending the Steno Diabetes Center in Denmark and have been ascribed to intensified glycemic control in the patient population.[@b12-clep-7-421] In this perspective, the emerging so-called diabetes epidemic is partly a result of improved care. We believe that the trends seen in the Danish population may be generalized to other nations with similar socioeconomic characteristics.

Our results have demonstrated that for incidence, complication, and mortality rates as well as prevalence proportions, men have higher levels than do females. Concerning incidence rates and prevalence proportions, this pattern was also observed from the first epidemiological analyses on the basis of NDR data,[@b11-clep-7-421] but so far these observations remain unexplained.

Together with our previously published study on the validation of the NDR,[@b8-clep-7-421] the results of the present study provide the basis of additional studies. As part of the Diabetes Impact Study 2013, we will perform in-depth analysis of the relative importance of those factors that drive the prevalence and use such models to establish scenarios for the future evolution of the prevalence of diabetes in Denmark, in line with similar approaches in other communities.[@b13-clep-7-421] New insight into the future societal burden of diabetes will be obtained by combining epidemiological data with information on patients' demographic, ethnic, and socioeconomic characteristics as well as estimates of costs attributable to diabetes within categories characterized by age, sex, and complication status.

Conclusion
==========

The prevalence of patients with diabetes registered in Denmark is rising exponentially due to the synergistic effect of increasing incidence combined with decreasing rate of developing complications as well as decreasing mortality in the patient population. Further studies will seek to quantify the relative importance of these factors, and this will enable for establishment of scenarios for estimating the future burden of diabetes.
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###### 

Grouping of diagnoses and interventions used for classifying hospital activities by complication groups of relevance for diabetes and with respect to diagnostic specificity for diabetes

  Diagnosis or procedure                                      Qualifying for complication group[a](#tfn1-clep-7-421){ref-type="table-fn"}   Specificity for diabetes[b](#tfn2-clep-7-421){ref-type="table-fn"}
  ----------------------------------------------------------- ----------------------------------------------------------------------------- --------------------------------------------------------------------
  Diabetes in pregnancy, childbirth, and the puerperium       0                                                                             1
  Diabetes, without indication of chronic complication        0                                                                             1
  Hypoglycemic coma not otherwise specified                   0                                                                             0
  Screening for diabetic retinopathy                          0                                                                             1
  Drug treatment or instruction specific for diabetes         0                                                                             1
  Acute myocardial infarction                                 1                                                                             0
  Diabetes with complication, not further specified           1                                                                             1
  Diabetes with complications in peripheral vascular system   1                                                                             1
  Diabetes with eye complication                              1                                                                             1
  Diabetes with foot ulcer                                    1                                                                             1
  Diabetes with microangiopathy                               1                                                                             1
  Diabetes with neurological complication                     1                                                                             1
  Diabetes with peripheral angiopathy                         1                                                                             1
  Diabetes with renal complication                            1                                                                             1
  Diabetic cataract                                           1                                                                             1
  Diabetic polyneuropathy                                     1                                                                             1
  Diabetic retinopathy not otherwise specified                1                                                                             1
  Diseases of the lens                                        1                                                                             0
  Polyneuropathy                                              1                                                                             0
  Proliferative diabetic retinopathy                          1                                                                             1
  Uremia                                                      1                                                                             0
  Simplex diabetic retinopathy                                1                                                                             1
  Cataract, retinopathy in diabetes                           1                                                                             1
  Diabetic angiopathy in extremities                          1                                                                             1
  Diabetic nephropathy, Kimmelstiel--Wilson syndrome          1                                                                             1
  Neuropathy, diabetic polyneuritis, diabetes                 1                                                                             1
  Amputation at or below ankle level                          1                                                                             0
  Coronary bypass operation                                   1                                                                             0
  Surgery for eye complication                                1                                                                             0
  Treatment of ulcer of lower limb                            1                                                                             0
  Diabetes with gangrene; diabetic gangrene                   2                                                                             1
  Diabetes with multiple complications                        2                                                                             1
  Diabetic maculopathy                                        2                                                                             1
  Dialysis                                                    2                                                                             0
  Diseases of the retina                                      2                                                                             0
  Heart failure                                               2                                                                             0
  Kidney transplantation                                      2                                                                             0
  Renal failure                                               2                                                                             0
  Stroke                                                      2                                                                             0
  Blindness                                                   2                                                                             0
  Gangrene of lower limb                                      2                                                                             0
  Intracerebral hemorrhage                                    2                                                                             0
  Amputation above ankle level                                2                                                                             0

**Notes:**

0, complication group 0 (no signs of complications); 1, complication group 1 (complications of moderate impact); 2, complication group 2 (complications of major impact);

values indicate specificity for diabetes (0, unspecific for diabetes; 1, specific for diabetes).

###### 

Summary of data by complication group

  Year        New cases of diabetes by complication status at diagnosis   Progressions to CG1 and CG2   Prevalent cases ultimo year by complication status   Number of deaths by complication status                                                                                 
  ----------- ----------------------------------------------------------- ----------------------------- ---------------------------------------------------- ----------------------------------------- ------- ------- --------- -------- -------- --------- ------- ------- ------- --------
  **All**                                                                                                                                                                                                                                                                            
  1999        NA                                                          NA                            NA                                                   NA                                        NA      NA      82,261    27,061   32,143   141,465   NA      NA      NA      NA
  2000        13,806                                                      1,825                         2,745                                                18,376                                    6,963   5,467   86,830    28,988   35,564   151,382   2,170   1,370   4,774   8,314
  2001        14,727                                                      2,020                         2,913                                                19,660                                    7,122   5,644   92,131    31,111   39,088   162,330   2,193   1,341   4,998   8,532
  2002        16,274                                                      2,189                         3,355                                                21,818                                    7,666   5,912   98,299    33,582   42,961   174,842   2,315   1,422   5,369   9,106
  2003        17,696                                                      2,432                         3,644                                                23,772                                    8,246   5,910   105,273   36,806   46,836   188,915   2,310   1,512   5,653   9,475
  2004        17,652                                                      2,388                         3,872                                                23,912                                    8,380   6,127   112,044   39,952   51,103   203,099   2,344   1,453   5,702   9,499
  2005        16,206                                                      2,343                         3,588                                                22,137                                    8,305   6,053   117,467   43,012   54,627   215,106   2,333   1,479   6,097   9,909
  2006        16,718                                                      2,442                         3,829                                                22,989                                    8,340   6,051   123,201   46,064   58,304   227,569   2,469   1,638   6,173   10,280
  2007        17,967                                                      2,411                         4,040                                                24,418                                    7,651   5,727   130,841   48,661   61,667   241,169   2,533   1,686   6,375   10,594
  2008        19,585                                                      2,720                         4,345                                                26,650                                    7,852   6,039   139,896   51,472   65,478   256,846   2,530   1,672   6,547   10,749
  2009        19,580                                                      2,641                         4,367                                                26,588                                    8,252   6,386   148,353   54,108   69,233   271,694   2,732   1,808   6,963   11,503
  2010        20,258                                                      2,762                         4,487                                                27,507                                    8,170   6,339   157,413   56,790   72,891   287,094   2,851   1,851   7,129   11,831
  2011        23,622                                                      3,107                         5,092                                                31,821                                    8,343   6,523   169,635   59,813   77,176   306,624   2,823   1,841   7,237   11,901
  **Men**                                                                                                                                                                                                                                                                            
  1999        NA                                                          NA                            NA                                                   NA                                        NA      NA      38,993    15,161   17,385   71,539    NA      NA      NA      NA
  2000        6,919                                                       1,128                         1,509                                                9,556                                     3,689   2,935   41,083    16,313   19,320   76,716    1,087   721     2,496   4,304
  2001        7,357                                                       1,232                         1,613                                                10,202                                    3,869   3,058   43,432    17,628   21,344   82,404    1,070   712     2,621   4,403
  2002        7,849                                                       1,368                         1,871                                                11,088                                    4,071   3,211   46,008    19,063   23,504   88,575    1,140   755     2,903   4,798
  2003        8,838                                                       1,524                         2,035                                                12,397                                    4,470   3,277   49,126    20,969   25,781   95,876    1,143   788     3,020   4,951
  2004        8,777                                                       1,513                         2,159                                                12,449                                    4,484   3,340   52,152    22,806   28,186   103,144   1,170   799     3,073   5,042
  2005        8,094                                                       1,451                         2,032                                                11,577                                    4,442   3,396   54,613    24,463   30,340   109,416   1,105   807     3,256   5,168
  2006        8,295                                                       1,588                         2,196                                                12,079                                    4,474   3,344   57,176    26,240   32,609   116,025   1,167   922     3,252   5,341
  2007        8,898                                                       1,536                         2,249                                                12,683                                    4,080   3,187   60,674    27,738   34,605   123,017   1,229   897     3,418   5,544
  2008        9,682                                                       1,806                         2,522                                                14,010                                    4,196   3,315   64,827    29,473   36,910   131,210   1,235   916     3,519   5,670
  2009        9,988                                                       1,713                         2,581                                                14,282                                    4,562   3,595   68,829    31,113   39,222   139,164   1,349   991     3,846   6,186
  2010        10,324                                                      1,803                         2,682                                                14,809                                    4,372   3,572   73,267    32,702   41,611   147,580   1,402   969     3,835   6,206
  2011        11,786                                                      2,000                         3,031                                                16,817                                    4,525   3,655   79,015    34,535   44,220   157,770   1,388   1,012   4,023   6,423
  **Women**                                                                                                                                                                                                                                                                          
  1999        NA                                                          NA                            NA                                                   NA                                        NA      NA      43,268    11,900   14,758   69,926    NA      NA      NA      NA
  2000        6,887                                                       697                           1,236                                                8,820                                     3,274   2,532   45,747    12,675   16,244   74,666    1,083   649     2,278   4,010
  2001        7,370                                                       788                           1,300                                                9,458                                     3,253   2,586   48,699    13,483   17,744   79,926    1,123   629     2,377   4,129
  2002        8,425                                                       821                           1,484                                                10,730                                    3,595   2,701   52,291    14,519   19,457   86,267    1,175   667     2,466   4,308
  2003        8,858                                                       908                           1,609                                                11,375                                    3,776   2,633   56,147    15,837   21,055   93,039    1,167   724     2,633   4,524
  2004        8,875                                                       875                           1,713                                                11,463                                    3,896   2,787   59,892    17,146   22,917   99,955    1,174   654     2,629   4,457
  2005        8,112                                                       892                           1,556                                                10,560                                    3,863   2,657   62,854    18,549   24,287   105,690   1,228   672     2,841   4,741
  2006        8,423                                                       854                           1,633                                                10,910                                    3,866   2,707   66,025    19,824   25,695   111,544   1,302   716     2,921   4,939
  2007        9,069                                                       875                           1,791                                                11,735                                    3,571   2,540   70,167    20,923   27,062   118,152   1,304   789     2,957   5,050
  2008        9,903                                                       914                           1,823                                                12,640                                    3,656   2,724   75,069    21,999   28,568   125,636   1,295   756     3,028   5,079
  2009        9,592                                                       928                           1,786                                                12,306                                    3,690   2,791   79,524    22,995   30,011   132,530   1,383   817     3,117   5,317
  2010        9,934                                                       959                           1,805                                                12,698                                    3,798   2,767   84,146    24,088   31,280   139,514   1,449   882     3,294   5,625
  2011        11,836                                                      1,107                         2,061                                                15,004                                    3,818   2,868   90,620    25,278   32,956   148,854   1,435   829     3,214   5,478

**Abbreviations:** CG0, no complications; CG1, minor complications; CG2, major complications; NA, not available.
